Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial Santiago Ponce Aix , Tudor Eliade Ciuleanu , Alejandro Navarro , Sophie Cousin , Laura Bonanno , Egbert F Smit , Alberto Chiappori , Maria Eugenia Olmedo , Ildiko Horvath , Christian Grohé , Anna F Farago , José Antonio López-Vilariño , Martin Cullell-Young , Antonio Nieto , Noelia Vasco , Javier Gómez , Carmen Kahatt , Ali Zeaiter , Enric Carcereny , Jaromir Roubec , Konstantinos Syrigos , Gregory Lo , Isidoro Barneto , Anthony Pope , Amparo Sánchez , Joseph Kattan , Konstantinos Zarogoulidis , Cornelius F Waller , Helge Bischoff , Oscar Juan-Vidal , Niels Reinmuth , Manuel Dómine , Luis Paz-Ares The Lancet Respiratory Medicine（2023）
关键词
lung cancer, chemotherapy, doxorubicin, small-cell, open-label
AI 理解论文
溯源树
样例
